JP2020506192A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020506192A5 JP2020506192A5 JP2019541718A JP2019541718A JP2020506192A5 JP 2020506192 A5 JP2020506192 A5 JP 2020506192A5 JP 2019541718 A JP2019541718 A JP 2019541718A JP 2019541718 A JP2019541718 A JP 2019541718A JP 2020506192 A5 JP2020506192 A5 JP 2020506192A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- och
- optionally substituted
- hydrogen
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 15
- -1 hydroxy Cyclohexyl Chemical group 0.000 claims 9
- 125000001424 substituent group Chemical group 0.000 claims 6
- 229910052739 hydrogen Inorganic materials 0.000 claims 5
- 239000001257 hydrogen Substances 0.000 claims 5
- 125000000131 cyclopropyloxy group Chemical group C1(CC1)O* 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 3
- 229910052736 halogen Inorganic materials 0.000 claims 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 3
- 125000006615 aromatic heterocyclic group Chemical group 0.000 claims 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- 150000002367 halogens Chemical class 0.000 claims 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 2
- 150000002431 hydrogen Chemical class 0.000 claims 2
- CUJPFPXNDSIBPG-UHFFFAOYSA-N 1,3-propanediyl Chemical group [CH2]C[CH2] CUJPFPXNDSIBPG-UHFFFAOYSA-N 0.000 claims 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 claims 1
- KZHUULABPNPTEO-UHFFFAOYSA-N 2-methoxy-2-phenylacetamide Chemical class COC(C(N)=O)C1=CC=CC=C1 KZHUULABPNPTEO-UHFFFAOYSA-N 0.000 claims 1
- WOGXHNJBKGZMHV-UHFFFAOYSA-N 2-methoxypropanamide Chemical compound COC(C)C(N)=O WOGXHNJBKGZMHV-UHFFFAOYSA-N 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 1
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 claims 1
- 125000002393 azetidinyl group Chemical group 0.000 claims 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 claims 1
- 125000004603 benzisoxazolyl group Chemical group O1N=C(C2=C1C=CC=C2)* 0.000 claims 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 claims 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 125000002837 carbocyclic group Chemical group 0.000 claims 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 206010022000 influenza Diseases 0.000 claims 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 claims 1
- LCEDQNDDFOCWGG-UHFFFAOYSA-N morpholine-4-carbaldehyde Chemical compound O=CN1CCOCC1 LCEDQNDDFOCWGG-UHFFFAOYSA-N 0.000 claims 1
- 125000001715 oxadiazolyl group Chemical group 0.000 claims 1
- 125000002971 oxazolyl group Chemical group 0.000 claims 1
- 125000004043 oxo group Chemical group O=* 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 125000003226 pyrazolyl group Chemical group 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- 125000000168 pyrrolyl group Chemical group 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 125000003831 tetrazolyl group Chemical group 0.000 claims 1
- 125000001113 thiadiazolyl group Chemical group 0.000 claims 1
- 125000001425 triazolyl group Chemical group 0.000 claims 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762453673P | 2017-02-02 | 2017-02-02 | |
| US62/453,673 | 2017-02-02 | ||
| EP17156448 | 2017-02-16 | ||
| EP17156448.7 | 2017-02-16 | ||
| PCT/EP2018/052537 WO2018141854A1 (en) | 2017-02-02 | 2018-02-01 | Piperazine derivatives for influenza virus inhibition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020506192A JP2020506192A (ja) | 2020-02-27 |
| JP2020506192A5 true JP2020506192A5 (enExample) | 2021-03-11 |
Family
ID=61192896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019541718A Pending JP2020506192A (ja) | 2017-02-02 | 2018-02-01 | インフルエンザウイルスを阻害するためのピペラジン誘導体 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US11040963B2 (enExample) |
| EP (1) | EP3577107A1 (enExample) |
| JP (1) | JP2020506192A (enExample) |
| AU (1) | AU2018216954B2 (enExample) |
| CA (1) | CA3052353A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10452480B2 (en) | 2017-05-25 | 2019-10-22 | Micron Technology, Inc. | Memory device with dynamic processing level calibration |
| US10140040B1 (en) | 2017-05-25 | 2018-11-27 | Micron Technology, Inc. | Memory device with dynamic program-verify voltage calibration |
| US10664194B2 (en) | 2018-05-16 | 2020-05-26 | Micron Technology, Inc. | Memory system with dynamic calibration using a variable adjustment mechanism |
| US10990466B2 (en) | 2018-06-20 | 2021-04-27 | Micron Technology, Inc. | Memory sub-system with dynamic calibration using component-based function(s) |
| US11188416B2 (en) | 2018-07-12 | 2021-11-30 | Micron Technology, Inc. | Enhanced block management for a memory sub-system |
| US11113129B2 (en) | 2018-07-13 | 2021-09-07 | Micron Technology, Inc. | Real time block failure analysis for a memory sub-system |
| US10936246B2 (en) | 2018-10-10 | 2021-03-02 | Micron Technology, Inc. | Dynamic background scan optimization in a memory sub-system |
| WO2021127472A1 (en) * | 2019-12-20 | 2021-06-24 | Landos Biopharma, Inc. | Lanthionine c-like protein 2 ligands, cells prepared therewith, and therapies using same |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100238346B1 (ko) * | 1993-04-07 | 2000-03-02 | 오쓰까 아끼히꼬 | 피페리딘 유도체를 유효성분으로 하는 말초혈관확장제 |
| US6984652B2 (en) * | 2003-09-05 | 2006-01-10 | Warner-Lambert Company Llc | Gyrase inhibitors |
| MY170607A (en) | 2006-09-07 | 2019-08-20 | Crucell Holland Bv | Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof |
| US9271962B2 (en) * | 2008-03-17 | 2016-03-01 | Northeastern University | Inhibitors of fatty acid amide hydrolase and monoacylglycerol lipase for modulation of cannabinoid receptors |
| WO2011015037A1 (en) * | 2009-08-05 | 2011-02-10 | The University Of Hongkong | Antiviral compounds and methods of making and using there of cross reference to related applications |
| ES2533068T3 (es) * | 2010-09-08 | 2015-04-07 | Bristol-Myers Squibb Company | Nuevos análogos de piperazina como antivirales de influenza de amplio espectro |
| KR101369584B1 (ko) | 2011-04-19 | 2014-03-06 | 일양약품주식회사 | 페닐-이속사졸 유도체 및 그의 제조방법 |
| JP5683752B2 (ja) | 2011-07-14 | 2015-03-11 | クルセル ホランド ベー ヴェー | 系統グループ１及び系統グループ２のインフルエンザａ型ウイルス、並びにインフルエンザｂ型ウイルスを中和することが可能なヒト結合分子 |
-
2018
- 2018-02-01 JP JP2019541718A patent/JP2020506192A/ja active Pending
- 2018-02-01 EP EP18704480.5A patent/EP3577107A1/en not_active Withdrawn
- 2018-02-01 CA CA3052353A patent/CA3052353A1/en active Pending
- 2018-02-01 AU AU2018216954A patent/AU2018216954B2/en not_active Ceased
- 2018-02-01 US US16/483,283 patent/US11040963B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020506192A5 (enExample) | ||
| RU2437877C2 (ru) | Новые производные тиофена в качестве агонистов рецептора s1p1/edg1 | |
| RU2317294C2 (ru) | (имидазол-1-илметил)пиридазин в качестве блокатора nmda рецептора | |
| RU2330019C2 (ru) | Производные пиперидина, способ их получения, фармацевтическая композиция на их основе и способ лечения хемокин-опосредованного болезненного состояния с их использованием | |
| RU2419626C2 (ru) | Соединения и композиции в качестве ингибиторов протеазы, активирующей каналы | |
| JP2010516635A5 (enExample) | ||
| JP2007519692A5 (enExample) | ||
| JP2020533352A5 (enExample) | ||
| JP2005500311A5 (enExample) | ||
| JP2017523972A5 (enExample) | ||
| RU2004133041A (ru) | Производные бензоксазинона, их получение и применение в качестве лекарственных средств | |
| JP2006508065A5 (enExample) | ||
| RU2004111285A (ru) | Оксазолидинон и/или изоксазолин в качестве антибактериальных средств | |
| JP2013510883A5 (enExample) | ||
| RU2007106928A (ru) | Производные бензилтриазолона в качестве ненуклеозидных ингибиторов обратной транскриптазы | |
| CA2494832A1 (en) | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives | |
| JP2015523980A5 (enExample) | ||
| RU2008119651A (ru) | Производные дикарбоновых кислот и их применение | |
| RU2011102396A (ru) | Аминосоединения и их медицинское применение | |
| TR199802253T2 (xx) | Alkilaminobenzotiazol ve benzoksazol t�revleri | |
| JP2005519885A5 (enExample) | ||
| RU2221788C2 (ru) | Оксоциклические соединения мочевины, фармацевтическая композиция, способ лечения | |
| JP2018510202A5 (enExample) | ||
| CA2547347A1 (en) | Diazaindole-dicarbonyl-piperazinyl antiviral agents | |
| PE20120732A1 (es) | Agonistas del receptor de esfingosina-1-fosfato |